Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Prostate-specific membrane antigen and its truncated form PSM'.

Mlcochová P, Barinka C, Tykvart J, Sácha P, Konvalinka J.

Prostate. 2009 Apr 1;69(5):471-9. doi: 10.1002/pros.20894.

PMID:
19107881
2.
3.

High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.

Cao KY, Mao XP, Wang DH, Xu L, Yuan GQ, Dai SQ, Zheng BJ, Qiu SP.

Prostate. 2007 Dec 1;67(16):1791-800.

PMID:
17929272
4.
5.

Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.

Schmittgen TD, Teske S, Vessella RL, True LD, Zakrajsek BA.

Int J Cancer. 2003 Nov 1;107(2):323-9.

6.

Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients.

Holmes EH, Greene TG, Tino WT, Boynton AL, Aldape HC, Misrock SL, Murphy GP.

Prostate Suppl. 1996;7:25-9.

PMID:
8950359
8.

Expression of the prostate-specific membrane antigen.

Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD.

Cancer Res. 1994 Apr 1;54(7):1807-11.

9.

Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing.

Castelletti D, Fracasso G, Alfalah M, Cingarlini S, Colombatti M, Naim HY.

J Biol Chem. 2006 Feb 10;281(6):3505-12. Epub 2005 Oct 12.

11.

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.

Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B, Heston WD.

Clin Cancer Res. 1996 Sep;2(9):1445-51.

12.

New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.

Cao KY, Xu L, Zhang DM, Zhang XM, Zhang T, He X, Wang Z, Feng FS, Qiu SP, Shen GX.

Int J Oncol. 2012 Jun;40(6):1977-85. doi: 10.3892/ijo.2012.1358. Epub 2012 Feb 6.

PMID:
22322627
13.

Measurement of prostate-specific membrane antigen in the serum with a new antibody.

Murphy GP, Tino WT, Holmes EH, Boynton AL, Erickson SJ, Bowes VA, Barren RJ, Tjoa BA, Misrock SL, Ragde H, Kenny GM.

Prostate. 1996 Apr;28(4):266-71.

PMID:
8602402
14.

Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line.

Troyer JK, Beckett ML, Wright GL Jr.

Prostate. 1997 Mar 1;30(4):232-42.

PMID:
9111600
15.

Detection of circulating prostate tumor cells: alternative spliced variant of PSM induced false-positive result.

Hisatomi H, Nagao K, Kawakita M, Matsuda T, Hirata H, Yamamoto S, Nakamoto T, Harasawa H, Kaneko N, Hikiji K, Tsukada Y.

Int J Mol Med. 2002 Nov;10(5):619-22.

PMID:
12373303
16.

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB.

Cancer Res. 1999 Jul 1;59(13):3192-8.

17.
18.

Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis.

Zhang L, Wang CY, Yang R, Shi J, Fu R, Chen L, Klocker H, Zhang J.

Urol Oncol. 2008 Nov-Dec;26(6):634-40. doi: 10.1016/j.urolonc.2007.07.016. Epub 2008 Jan 14.

PMID:
18367130
19.

Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.

Lane Z, Hansel DE, Epstein JI.

Am J Surg Pathol. 2008 Sep;32(9):1322-6. doi: 10.1097/PAS.0b013e3181656ca0.

PMID:
18670358
20.

Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.

Chang SS, Reuter VE, Heston WD, Gaudin PB.

Urology. 2001 Apr;57(4):801-5.

PMID:
11306418

Supplemental Content

Support Center